Does MONTELUKAST Cause Bronchial secretion retention? 240 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 240 reports of Bronchial secretion retention have been filed in association with MONTELUKAST (Montelukast). This represents 0.9% of all adverse event reports for MONTELUKAST.
240
Reports of Bronchial secretion retention with MONTELUKAST
0.9%
of all MONTELUKAST reports
0
Deaths
194
Hospitalizations
How Dangerous Is Bronchial secretion retention From MONTELUKAST?
Of the 240 reports, 194 (80.8%) required hospitalization, and 55 (22.9%) were considered life-threatening.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 240 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
ACETAMINOPHEN (151)
Which MONTELUKAST Alternatives Have Lower Bronchial secretion retention Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE